Table 2.
Adjusted Changes in HbA1c Values Compared with Baseline by HIV Infection Status and Duration of Therapy.
| Duration of Therapy (Post-Index Date) | Change From Baseline, % (95% CI)a | Difference Between HIV-Infected and HIV-Uninfected Patients (95% CI)b |
|---|---|---|
| 1–3 months | −1.11 (−0.96, −1.26) | −0.17 (−0.28, −0.06) |
| 4–6 months | −1.20 (−1.05, −1.36) | |
| 7–9 months | −1.15 (−1.00, −1.31) | |
| 10–12 months | −1.04 (−0.87, −1.22) |
Abbreviations: HbA1c, hemoglobin A1c; CI, confidence interval.
a
Absolute reduction in HbA1c (%).
b
Of absolute reduction in HbA1c (%), with reference group patients without HIV infection.